NanoMedSyn
Enhancing therapies with proteins
- B2B
About NanoMedSyn
NanoMedSyn develops breakthrough technology for drug delivery to lysosomal cells, enhancing therapeutic potency, with applications in oncology, immunity, inflammation, and metabolism
Key facts
- Industry
- Biotechnology
- Company size
- 1–10 employees
- Headquarters
- Montpellier, Occitanie, France
- Founded
- 2012
- Revenue
- $2.6M – $20.4MTamtam estimate
- Website
- nanomedsyn.com
- linkedin.com/company/nanomedsyn
NanoMedSyn at a glance
NanoMedSyn is a B2B company in the Biotechnology industry, headquartered in Montpellier, Occitanie, France.
NanoMedSyn was founded in 2012.
NanoMedSyn has 1–10 employees.
NanoMedSyn's revenue is $2.6M – $20.4M (Tamtam estimate).
Selling to companies like NanoMedSyn?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies